Simultaneous deletion of endogenous TCR alpha beta for TCR gene therapy creates an improved and safe cellular therapeutic

Author(s):: Morton, L.T.; Reijmers, R.M. (0000-0001-7471-7715); Wouters, A.K.; Kweekel, C.; Remst, D.F.G.; Pothast, C.R. (0000-0002-9761-3123); Falkenburg, J.H.F. (0000-0002-9819-4813); Heemskerk, M.H.M. (0000-0001-6320-9133)

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-01-08
Language: English
Publisher: Cell Press
Is part of: Molecular Therapy (2020), Vol. 28, no. 1, p. 64-74
hdl: 1887/3181451
doi: 10.1016/j.ymthe.2019.10.001
URL: https://www.sciencedirect.com/science/article/pii/S1525001619304551?via%3Dihub